Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma

Pathobiology

Volumn 71, Issue 3, 2004, Pages 137-143

  Oshimo, Yasuhiro ^a   Oue, Naohide ^a   Mitani, Yoshitsugu ^a   Nakayama, Hirofumi ^a   Kitadai, Yasuhiko ^a   Yoshida, Kazuhiro ^b   Ito, Yoshiaki ^c   Chayama, Kazuaki ^a   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

DNA methylation; Epigenetic; Gastric carcinoma; RUNX3; Transforming growth factor beta

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR RUNX3;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CARCINOMA CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; FEMALE; GENE INACTIVATION; GENETIC TRANSCRIPTION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE TUMOR; MALE; MEASUREMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER HYPERMETHYLATION; PROMOTER REGION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA METHYLATION; DNA, NEOPLASM; DNA-BINDING PROTEINS; GASTRIC MUCOSA; GENE SILENCING; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 1842455990     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076468     Document Type: Article

References (34)

1. Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H, Tahara E: Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol 2000;35:111-115.
2. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE: E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402-405.
3. Kim JH, Takahashi T, Chiba I, Park JG, Birrer MJ, Roh JK, De Lee H, Kim JP, Minna JD, Gazdar AF: Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J Natl Cancer Inst 1991;83:938-943.
4. Park K, Kim SJ, Bang YJ, Park JG, Kim NK, Roberts AB, Sporn MB: Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-beta. Proc Natl Acad Sci USA 1994;91:8772-8776.
5. Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou TT, Abraham JM, Kong D, Smolinski KN, Shi YQ, Rhyu MG, Powell SM, James SP, Wilson KT, Herman JG, Meltzer SJ: Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999;59:1090-1095.
6. Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, Ho JC: hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999;59:159-164.
7. Shim YH, Kang GH, Ro JY: Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab Invest 2000;80:689-695.
8. Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ: E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 2000;92:569-573.
9. Oue N, Shigeishi H, Kuniyasu H, Yokozaki H, Kuraoka K, Ito R, Yasui, W: Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. Int J Cancer 2001;93:805-809.
10. Hayashi K, Yokozaki H, Goodison S, Oue N, Suzuki T, Lotan R, Yasui W, Tahara E: Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer. Differentiation 2001;68:13-21.
11. Byun DS, Lee MG, Chae KS, Ryu BG, Chi SG: Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res 2001;61:7034-7038.
12. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y: Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;109:113-124.
13. Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo WH, Imamura T, Ishidou Y, Fukuchi M, Shi MJ, Stavnezer J, Kawabata M, Miyazono K, Ito Y: Interaction and functional cooperation of PEBP2/CBF with Smads: Synergistic induction of the immunoglobulin germline C alpha promoter. J Biol Chem 1999; 274:31577-31582.
14. Lauren P: The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma: An attempt at histological classification. Acta Pathol Microbiol Scand 1965;64:31-49.
15. Shimoyama Y, Hirohashi S: Expression of E- and P-cadherin in gastric carcinomas. Cancer Res 1991;51:2185-2192.
16. Sobin LH, Wittekind CH (eds): TNM Classification of Malignant Tumors, ed 5. New York, Wiley-Liss, 1997, pp 59-62.
17. Ochiai A, Yasui W, Tahara E: Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn J Cancer Res 1995;76:1064-1071.
18. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-9826.
19. Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-3229.
20. Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin SB, Issa JP: Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999;59:5438-5442.
21. Tsuchiya T, Tamura G, Sato K, Endoh Y, Sakata K, Jin Z, Motoyama T, Usuba O, Kimura W, Nishizuka S, Wilson KT, James SP, Yin J, Fleisher AS, Zou T, Silverberg SG, Kong D, Meltzer SJ: Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 2000;19:3642-3646.
22. Sato K, Tamura G, Tsuchiya T, Endoh Y, Usuba O, Motoyama T: Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer. Br J Caner 2001;85:199-203.
23. Riggins AB, Kinzler KW, Vogelstein B, Thiagalingam S: Frequency of Smad gene mutations in human cancers. Cancer Res 1997;57:2578-2580.
24. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana L, Attisano L: MADR2 maps to 18q21 and encodes a TGF-beta-regulated MAD-related protein that is mutated in colorectal carcinoma. Cell 1996;86:543-552.
25. Makkowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKV: Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-1338.
26. Nishizuka S, Tamura G, Maesawa C, Sakata K, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R: Analysis of the DPC4 gene in gastric carcinoma. Jpn J Cancer Res 1997;88:335-339.
27. Shitara Y, Yokozaki H, Yasui W, Takenoshita S, Kuwano H, Nagamachi Y, Tahara E: No mutations of Smad2 gene in human sporadic gastric carcinomas. Jpn J Clin Oncol 1999;29:3-7.
28. Shitara Y, Yokozaki H, Yasui W, Takenoshita S, Nagamachi Y, Tahara E: Mutation of the transforming growth factor-beta type II receptor gene is a rare event in human sporadic gastric carcinomas. Int J Oncol 1998;12:1061-1065.
29. Renault B, Calistri D, Buonsanti G, Nanni O, Amadori D, Ranzani GN: Microsatellite instability and mutations of p53 and TGF-beta RII genes in gastric cancer. Hum Genet 1996;98:601-607.
30. Oue N, Sentani K, Yokozaki H, Kitadai Y, Ito R, Yasui W: Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa. Pathobiology 2001;69:143-149.
31. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG: CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001;61:2847-2851.
32. To KF, Leung WK, Lee TL, Yu J, Tong JH, Chan MW, Ng EK, Chung SC, Sung JJ: Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 2002;102:623-628.
33. Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S, Motoyama T: Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol 2002;161:399-403.
34. Baylin SB, Herman J G, Graff JR, Vertino PM, Issa JP: Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res 1998;72:141-196.